[{"Assets_0_Q2_USD":314960000.0,"CommonStockSharesOutstanding_0_Q2_shares":124999365.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-86111000.0,"NetIncomeLoss_1_Q2_USD":-63266000.0,"NetIncomeLoss_2_Q2_USD":-117562000.0,"StockholdersEquity_0_Q2_USD":264720000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":57063000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":105931000.0,"Ticker":"ACAD","CIK":"1070494","name":"ACADIA PHARMACEUTICALS INC","OfficialName":"ACADIA Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3501345407.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180808"}]